Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
The FDA has approved AstraZeneca's treatment for use outside of healthcare facilities, but it will still require a prescription.
On Friday, the FDA approved the at-home use of FluMist, allowing those who are hesitant about needles to access a potentially lifesaving nasal spray flu vaccine more easily.
This marks the first time parents can administer the vaccine to children, and adults can use it themselves outside of a healthcare facility, although a prescription will still be necessary. FluMist is expected to be available from online pharmacies by next fall.
AstraZeneca, the producer, plans to launch a FluMist Home website where users can complete a questionnaire reviewed by a pharmacist before the treatment is shipped directly to them. The nasal spray will also remain available for in-office use. The current cost for a dose is approximately $35 to $45, depending on insurance coverage.
Dr. Peter Marks, director of the FDA’s vaccine center, emphasized that this approval offers a convenient option for families to receive a safe and effective flu vaccine. The FDA required AstraZeneca to demonstrate that the instructions for at-home use were clear and feasible, concluding that they were, but recommending that caregivers administer the spray to children aged 2 to 17.
Dr. Abraar Karan, an infectious disease specialist, noted that logistical barriers often prevent people from getting vaccinated, including the need for appointments and recovery time. He believes that the new at-home option will reduce these barriers and encourage more people to get vaccinated before flu season begins.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment